DWP450 for Treating Moderate to Severe Glabellar Lines
Status:
COMPLETED
Trial end date:
2021-01-25
Target enrollment:
Participant gender:
Summary
A multi-center, randomized, double-blind, positive drug-controlled clinical study to evaluate the safety and efficacy of Botulinum Toxin Type A for Injection in the treatment of moderate to severe glabellar lines